Home › Funds › Point72 Asset Management › BLTE
Point72 Asset Management position in BLTE
BELITE BIO INC · Health Care
Latest position (Q2 2026)51.19K sh
Reported value held$7.88M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 7.70K | $352.27K | New |
| Q1 2024 | 8.70K | $333.82K | Add |
| Q2 2024 | 7.31K | $333.97K | Reduce |
| Q3 2024 | 4.80K | $225.02K | Reduce |
| Q2 2025 | 1.30K | $75.01K | New |
| Q3 2025 | 3.10K | $229.40K | Add |
| Q4 2025 | 284.44K | $45.50M | Add |
| Q2 2026 | 51.19K | $7.88M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BLTE
- Millennium Management 494.56K sh · $76.16M · Q2 2026
- Maverick Capital 396.31K sh · $61.03M · Q2 2026
- Morgan Stanley 235.07K sh · $36.20M · Q2 2026
- UBS Group AG 224.99K sh · $34.64M · Q2 2026
- Citadel Advisors 186.17K sh · $28.67M · Q2 2026
- Goldman Sachs Group 166.19K sh · $25.59M · Q2 2026
- Bank of America Corp 124.78K sh · $19.21M · Q2 2026
- Renaissance Technologies 55.76K sh · $8.59M · Q2 2026
- Two Sigma Investments 38.10K sh · $5.87M · Q2 2026
- JPMorgan Chase & Co 33.18K sh · $5.13M · Q2 2026
- Geode Capital Management 22.64K sh · $3.49M · Q2 2026